Latest filings (excl ownership)
8-K
Cue Health to Pursue Wind Down of the Business
28 May 24
8-K
Departure of Directors or Certain Officers
16 May 24
NT 10-Q
Notice of late quarterly filing
16 May 24
8-K
Cost Associated with Exit or Disposal Activities
1 May 24
8-K
Departure of Directors or Certain Officers
24 Apr 24
ARS
2023 FY
Annual report to shareholders
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
PRE 14A
Preliminary proxy
11 Apr 24
8-A12B/A
Registration of securities on exchange (amended)
9 Apr 24
8-K
Entry into a Material Definitive Agreement
9 Apr 24
8-K
Departure of Directors or Certain Officers
29 Mar 24
8-K
Cue Health Announces Strategic Actions to Position Company for Next Stage
20 Mar 24
S-8
Registration of securities for employees
13 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
8-K
Cue Health Reports Fourth Quarter 2023 Financial Results
13 Mar 24
8-K
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
16 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
25 Jan 24
8-K
Cost Associated with Exit or Disposal Activities
5 Jan 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Cue Health Reports Third Quarter 2023 Financial Results
8 Nov 23
8-A12B
Registration of securities on exchange
21 Sep 23
8-K
Entry into a Material Definitive Agreement
21 Sep 23
8-K
Entry into a Material Definitive Agreement
9 Aug 23
424B5
Prospectus supplement for primary offering
9 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Cue Health Reports Second Quarter 2023 Financial Results
9 Aug 23
EFFECT
Notice of effectiveness
7 Aug 23
8-K
The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes
3 Aug 23
CORRESP
Correspondence with SEC
2 Aug 23
S-3/A
Shelf registration (amended)
31 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
Regulation FD Disclosure
6 Jun 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Cue Health Reports First Quarter 2023 Financial Results
10 May 23
ARS
2022 FY
Annual report to shareholders
8 May 23
8-K
Cost Associated with Exit or Disposal Activities
28 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
UPLOAD
Letter from SEC
27 Mar 23
8-K
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
20 Mar 23
Latest ownership filings
4/A
Aasim Javed
21 May 24
SC 13D/A
Tarsadia Capital, LLC
17 May 24
4
Clint Sever
27 Mar 24
4
Randall E. Pollard
7 Mar 24
4
Christopher K Achar
7 Mar 24
4
Aasim Javed
7 Mar 24
4
Clint Sever
7 Mar 24
4
Ayub K Khattak
7 Mar 24
4
Christopher K Achar
27 Feb 24
4
Randall E. Pollard
27 Feb 24
4
Aasim Javed
27 Feb 24
4
Clint Sever
27 Feb 24
4
Ayub K Khattak
27 Feb 24
4
RISHI REDDY
27 Feb 24
3
RISHI REDDY
27 Feb 24
SC 13D/A
Tarsadia Capital, LLC
21 Feb 24
SC 13G/A
Khattak Ayub K
14 Feb 24
SC 13G/A
KSP Cue Health Investments, LLC
9 Feb 24
4
Clint Sever
28 Dec 23
4
Ayub K Khattak
28 Dec 23
4
Aasim Javed
7 Dec 23
4
Ayub K Khattak
7 Dec 23
4
Christopher K Achar
7 Dec 23
4
Clint Sever
7 Dec 23
4
Randall E. Pollard
7 Dec 23
4
Erica Palsis
7 Dec 23
SC 13D
OAKMONT Corp
16 Oct 23
4
Christopher K Achar
27 Sep 23
4
Ayub K Khattak
27 Sep 23
4
Clint Sever
27 Sep 23
3
Initial statement of insider ownership
22 Sep 23
SC 13D/A
Tarsadia Capital, LLC
18 Sep 23
SC 13D
Tarsadia Capital, LLC
11 Sep 23
4
Aasim Javed
7 Sep 23
4
Christopher K Achar
7 Sep 23
4
Clint Sever
7 Sep 23
4
Ayub K Khattak
7 Sep 23
4
Randall E. Pollard
7 Sep 23
4
Erica Palsis
7 Sep 23
4
Ayub K Khattak
28 Jun 23